Azenta Inc (NAS:AZTA)
$ 46.21 -0.9 (-1.91%) Market Cap: 2.11 Bil Enterprise Value: 1.70 Bil PE Ratio: 0 PB Ratio: 1.19 GF Score: 74/100

Azenta Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 07:35PM GMT
Release Date Price: $39.95 (-1.79%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

I guess we can get started. Good afternoon, everybody. I'm Luke Sergott. I cover the Life Science Tools and Diagnostics here at Barclays. I have Vandana and Lindon here from Azenta. And we are going to do a presentation, and then we can just jump in with questions.

If that's okay. Vandana Sriram our Senior VP of Finance, will present.

Vandana Sriram
Azenta, Inc. - Senior VP of Global Finance, Corporate Controller & Principal Accounting Officer

Great. Thank you so much. I'd love to give you an overview of just who we are, a little bit of our history, and then talk a little bit about our products and our growth prospects. And then we'd love to take questions from the audience. We'll try to wrap this up so we have enough time for questions.

Firstly, before we get started, I'd like to address the safe harbor statement. We were making some forward-looking statements here, and we would encourage you to look at our website for more complete disclosure. We will also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot